Pro-Social AI For Alzheimer’s Prevention Tech November 6, 2024 November is National Alzheimer’s Awareness Month, a time to reflect on how emerging technologies can address the urgent need for…
UK’s NICE Says Alzheimer’s Disease Drug Kisunla Is Not Cost-Effective Tech November 2, 2024 The United Kingdom medicines authority approved the Alzheimer’s disease drug Kisunla (donanemab) last week for certain patients. This follows the…